Search - tctmd.com

Displaying 861 - 880 of 981

Sort: Relevancy | Date

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

January 01, 2014

Impella Pump – User Friendly Device for Left Ventricle Assist not Only in Patients with Cardiogenic Shock but also with Low Ejection Fraction Scheduled for Eligible PCI

Presentation

Impella Pump – User Friendly Device for Left Ventricle Assist not Only in Patients with Cardiogenic Shock but also with Low Ejection Fraction Scheduled for Eligible PCI

Presenter: Robert J. Gil

December 02, 2013

Aortic Insufficiency Following Left Ventricular Assist Device Implantation – an Old Impediment with New Solutions?

Presentation

Aortic Insufficiency Following Left Ventricular Assist Device Implantation – an Old Impediment with New Solutions?

Presenter: Jacob Lavee

December 02, 2013

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

November 16, 2013

Case #2 - Parachute Device for Left Ventricular Failure

Presentation TCT 2013

Case #2 - Parachute Device for Left Ventricular Failure

Presenter: Robaayah Zambahari

October 30, 2013

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Presentation TCT 2013

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Presenter: Alexandra Lansky

October 30, 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presentation TCT 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presenter: E. Murat Tuzcu

October 30, 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Presentation TCT 2013

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Presenter: Jeffrey Popma

October 30, 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Presentation TCT 2013

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Presenter: Leo Marcoff

October 29, 2013

Editorial Comment: TAVR Patient and Device Selection, Complications and Outcomes

Presentation TCT 2013

Editorial Comment: TAVR Patient and Device Selection, Complications and Outcomes

Presenter: Ramon Quesada

October 28, 2013

Newer Generation Devices for Valve Implantation: Differentiating Features

Presentation TCT 2013

Newer Generation Devices for Valve Implantation: Differentiating Features

Presenter: Hans Figulla

October 28, 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presentation TCT 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presenter: Nicolas van Mieghem

October 28, 2013

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Presentation TCT 2013

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Presenter: Hans Figulla

October 28, 2013

Do I Need Newer Generation TAVR Devices in the USA?

Presentation TCT 2013

Do I Need Newer Generation TAVR Devices in the USA?

Presenter: Ted Feldman

October 28, 2013

Do I Need Newer Generation TAVR Devices in Germany?

Presentation TCT 2013

Do I Need Newer Generation TAVR Devices in Germany?

Presenter: Joachim Schofer

October 28, 2013

Strengthening Our National System for Medical Device Postmarket Surveillance

Presentation TCT 2013

Strengthening Our National System for Medical Device Postmarket Surveillance

Presenter: John Laschinger

October 27, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.